Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06604130
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
None
First Post:
2024-09-13
Brief Title:
Plasma Exosome RNA to Diagnose Prostate Cancer
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Plasma Exosome RNA Combination for Diagnosing Prostate Cancer a Prospective Multicenter Diagnostic Trial
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
exo-PRECISE
Brief Summary:
The aim of the present study is to investigate a RNA combination to diagnose prostate cancer
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None